i-Motif DNA: Unlacing the Tetramer Cytosine-Cytosine DNA Structure

by: Jared Von Santiago (Fosmid)

    DNA is composed of nucleic base pairs that form hydrogen bonds. Purines like guanine and adenine form hydrogen bonds with pyrimidines, cytosine, and thymine to form the DNA double-stranded helix structure. I-motif DNA is a different structure. Under acidic conditions, the cytosine pairs with another cytosine and causes the DNA to fold and form a different structure. Imagine tying your shoelaces together (conventional DNA structure), and one of the laces forms a knot with itself—that’s the i-motif DNA structure!


    In 1993, Kalleh Gehring, Jean-Louis Leroy, and Maurice Guéron discovered the i-motif DNA structure in vitro under acidic conditions. However, the biological relevance of i-motif remained uncertain due to a lack of in vivo studies of i-motif. Mahdi Zeraati et al. (2018) proved that i-motif can form naturally in vivo. They generated and characterized an antibody that would directly visualize the i-motif structure in the nuclei of human cells, solidifying the presence of i-motifs in physiological conditions and their potential function in cellular processes.


    The i-motif structure is produced from the folding of cytosine-rich nucleic acid sequences. I-motifs are formed by the base pairing of cytosine with protonated cytosine. As observed by Gehring et al. (1993), i-motifs present stability in acidic pH levels (optimal between pH 4.0 and 5.0). In vivo studies of i-motif sought to address the formation of i-motifs under physiological conditions (pH 7.0-7.4). In a study by Deep et al. (2025), i-motif formation was observed in the nuclei of cancer cell lines under physiological conditions, implying that other factors may play a role in i-motif formation and stability other than pH level, which has been intensively studied, such as temperature and molecular crowding.


Photo from Deep et al. (2025)

    The i-motif plays an important role in transcriptional regulation of gene expression, serving as a regulatory switch, leading to changes in the phenotype and cell cycle behavior. A novel practical application of i-motifs is in cancer therapy and drug development. I-motifs can be found in the promoter regions of oncogenes, or genes that, when mutated, can induce cancer. For example, in a promoter of BCL2, an anti-apoptotic gene, studies have shown that stabilizing i-motifs can enhance gene expression of BCL2, protecting cells from dying. Conversely, disrupting them with an i-motif destabilizer can downregulate gene expression, leading to apoptosis and tumor size reduction.


Photo from Deep et al. (2025)

    From mere DNA structures commonly observed under acidic conditions, studies on i-motifs continue to elucidate their role in gene regulation, cell function, and their clinical applications in pathophysiology and disease treatment. Current i-motif research is not limited to oncological studies but even extends to neurological and metabolic disorders, aging, epigenetic regulation, and other molecular biological and clinical applications.



SOURCES

Deep, A., Bhat, A., Perumal, V., & Kumar, S. (2025). i-Motifs as Regulatory Switches: Mechanisms and Implications for Gene Expression. Molecular Therapy — Nucleic Acids, 36(1), 102474–102474. https://doi.org/10.1016/j.omtn.2025.102474

Gehring, K., Leroy, J.-L., & Guéron, M. (1993). A tetrameric DNA structure with protonated cytosine-cytosine base pairs. Nature, 363(6429), 561–565. https://doi.org/10.1038/363561a0

Zeraati, M., Langley, D. B., Schofield, P., Moye, A. L., Rouet, R., Hughes, W. E., Bryan, T. M., Dinger, M. E., & Christ, D. (2018). I-motif DNA structures are formed in the nuclei of human cells. Nature Chemistry, 10(6), 631–637. https://doi.org/10.1038/s41557-018-0046-3


This article was originally published in the GENEWS May 2025 Issue.

0 Comments